Castle Biosciences CSTL 深 沪
已收盘 10-30 16:00:00 美东时间
37.16
-1.350
-3.51%
华盛通- 最 高38.43
- 今 开38.03
- 成交量 33.43万股
- 最 低 36.73
- 昨 收 38.51
- 总市值 11.35亿
- 52周最高 44.28
- 市盈率 静 --
- 换手率 1.09%
- 52周最低 17.722
- 委 比 97.80%
- 总股本 3054.95万
- 历史最高 107.69
- 量 比 0.88
- 振 幅 4.41%
- 历史最低 9.2601
- 每 手 1
- 风险率 6.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Castle Biosciences收涨0.67%，成交额784.1万美元
10月27日，Castle Biosciences（CSTL）收涨0.67%，报33.3美元，成交额784.1万美元，市值10.17亿美元。 行情数据 • 开盘...
10-27 05:45
Castle Biosciences收跌5.44%，成交额1229.95万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:48
Castle Biosciences Announces Opening Of New Laboratory And Office Facility In Scottsdale, Arizona
New 55,000-square-foot facility expands Castle's operational footprint in Arizona to support growing test volumes and long-term growth FRIENDSWOOD, Texas, Sept. 22, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient car...
09-22 19:13
JAAD Publication Shows Improved Performance of DecisionDx®-SCC
DecisionDx-SCC shows enhanced performance with the integration of select clinicopathologic risk factors, providing a more precise result to support risk-aligned patient management DecisionDx...
09-10 04:30
SciBase receives additional order from Castle Biosciences, advancing the collaboration
STOCKHOLM, Sept. 8, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leader in AI-based devices for detection and prevention in dermatology, today announces that it has rec...
09-08 21:30
Castle Biosciences Approved for Dual Listing on Nasdaq Texas
FRIENDSWOOD, Texas, Aug. 17, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that i...
08-17 19:00
Castle Biosciences Ups 2026 Outlook Amid Growth
Castle Biosciences (($CSTL)) has held its Q2 earnings call. Read on for the mai...
08-10 08:28
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Castle Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2026 sales guidance above estimates.
Castle Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2026 sales guidance above estimates.
07-31 04:54
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
FRIENDSWOOD, Texas, July 22, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that i...
07-22 19:00
